PofoliaShared via Pofolia

Hepatology· 2017Q1

AASLD guidelines for the treatment of hepatocellular carcinoma

Julie K. Heimbach, Laura Kulik, Richard S. Finn, Claude B. Sirlin et al.

Short summary

The American Association for the Study of Liver Diseases (AASLD) has released updated guidelines for HCC treatment in adults with cirrhosis, adhering to Institute of Medicine standards and employing the GRADE approach.

AI-generated from the title and abstract; the full text is not read.

Key points

  • New AASLD guidelines for HCC treatment in adults with cirrhosis.
  • Guidelines adhere to Institute of Medicine standards for trustworthiness.
  • The GRADE approach was used to develop recommendations.
  • Multiple systematic literature reviews underpin the recommendations.

AI-generated from the title and abstract; the full text is not read.

Abstract

This document presents official recommendations of the American Association for the Study of Liver Diseases (AASLD) on the surveillance, diagnosis, and treatment of hepatocellular carcinoma (HCC) occurring in the setting of adults with cirrhosis. Unlike previous AASLD practice guidelines, the current guideline was developed in compliance with the Institute of Medicine standards for trustworthy practice guidelines and uses the Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach. Multiple systematic reviews of the literature were conducted to support the recommendations in this practice guideline. An enhanced understanding of the guideline can be obtained by reading the applicable portions of the systematic reviews. In addition, more detailed information may be found in the associated guidance document related to clinically important aspects of HCC that lacked sufficient evidence to warrant a systematic review.

The authors' abstract, as published at the source. Hepatology, 2017 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Hepatology

HepatologyMedicine